EMBO

What EMBO does

EMBO (European Molecular Biology Organization) is a non-profit scientific organization founded in 1964 and headquartered in Heidelberg, Germany. It promotes excellence in the life sciences across Europe and globally by serving life scientists at all career stages — from postdoctoral researchers to established group leaders — through a portfolio of funding, training, publishing, and recognition programmes. Its core products include the EMBO Fellowship Programme, Young Investigator Programme, Installation Grants (€50,000 annually for 3–5 years), Global Investigator Network, Scientific Exchange Grants, the EMBO | Helmholtz Biomedical Engineering Workshop, and prestige awards such as the EMBO Gold Medal and the FEBS|EMBO Women in Science Award. The organization also publishes six peer-reviewed journals under EMBO Press (The EMBO Journal, EMBO reports, Molecular Systems Biology, EMBO Molecular Medicine, Life Science Alliance, plus management of Review Commons) and operates infrastructure platforms including Review Commons (a journal-independent preprint peer review platform co-founded with ASAPbio in 2019 and integrated with 17 affiliate journals) and SourceData (a structured research-data metadata platform).

EMBO's underlying technology stack is built around scientific publishing and open-science infrastructure rather than commercial software products. Approximately 80 scientific events per year are funded across EMBC member states, and EMBO maintains an internal OAuth2-based identity system (identity.embo.org) for member authentication. The Young Investigator Network connects more than 600 scientists, while the broader EMBO membership exceeds 2,100 leading life scientists who provide scientific governance.

EMBO's revenue model is a hybrid of inter-governmental funding and earned publication income. Primary financing flows through the European Molecular Biology Conference (EMBC), an inter-governmental organization of 32 member states established in 1969 to provide stable long-term support for EMBO programmes. Supplementary revenue is generated through EMBO Press journal operations (article processing charges and subscriptions, distributed in partnership with Springer Nature, Rockefeller University Press, and Cold Spring Harbor Laboratory Press) and external grants — notably a Howard Hughes Medical Institute grant supporting Review Commons. EMBO's customer base is diffuse: tens of thousands of life scientists across 32 EMBC member states and global partner countries (India, Singapore, Taiwan, Chile, Japan, Brazil, Canada, China, Mexico, South Korea), with no individual recipient material to its overall funding base.

Name

EMBO

Legal name

European Molecular Biology Organization (EMBO)

Website

https://embo.org

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

11–50 employees

Short description

EMBO is a non-profit organization founded in 1964 that supports life scientists across Europe and globally through fellowships, grants, training programmes, scientific publishing via EMBO Press, and prestigious awards, primarily funded by the 32-state EMBC inter-governmental framework.

Ownership category

akta.pro rank

Product category

Scientific Research Funding and Publishing

NAICS

Educational Services (61), Exam Preparation and Tutoring (611691)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Emergency Medical Services (EMT/Paramedic) Training (EDAOAMAC)

akta.pro secondary industries

Charter School Management Organizations (CMOs/EMOs) (EDAJACAA), Model United Nations (MUN) (EDAMAGAB), AAC (Augmentative & Alternative Communication) Devices, Apps & Training (EDAKAIAB), Emergency Education / Education in Emergencies (EiE) (BPADADAN), MBA & Executive MBA Programs (EDAHAHAB)

Keywords

• Scientific research funding
• Postdoctoral fellowships
• Scientific publishing journals
• Life sciences training
• Research grants programs

Headquarters

HQ city

Heidelberg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. EMBC Member State Funding: EMBO is primarily funded through the European Molecular Biology Conference (EMBC), an inter-governmental organization comprising 32 member states. EMBC provides stable long-term financing for EMBO's programs and activities.
2. Publication Fees and Journal Operations: EMBO Press generates revenue through article processing charges and journal subscriptions for its portfolio of six peer-reviewed journals.
3. External Grants and Partnerships: EMBO receives grants from organizations such as Howard Hughes Medical Institute (HHMI) for specific initiatives like Review Commons, and collaborates with partners for joint events and programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

EMBO is a non-profit scientific organization that promotes excellence in life sciences through fellowships, grants, training programmes, scientific publishing, and awards. It funds postdoctoral fellowships, the Young Investigator Programme, Installation Grants, the Global Investigator Network, scientific exchange grants, and approximately 80 workshops and courses per year. It also publishes peer-reviewed journals via EMBO Press and operates the Review Commons preprint peer-review platform.

Product overview

EMBO (European Molecular Biology Organization) is a scientific organization promoting excellence in life sciences, not a traditional technology product company. Its portfolio consists of funding programmes, scientific journals, professional development offerings, and award schemes. The core offerings include: fellowship programmes (long-term and short-term postdoctoral fellowships), career development programmes (Young Investigator Programme, Global Investigator Network, Installation Grants), scientific publishing (EMBO Press journals including The EMBO Journal, EMBO reports, Molecular Systems Biology, EMBO Molecular Medicine, and Life Science Alliance), conference and training offerings (Courses & Workshops, Lab Leadership Courses), preprint peer review services (Review Commons), data infrastructure (SourceData), science journalism support (Maria Leptin fellowships), and prestigious awards (EMBO Gold Medal, FEBS|EMBO Women in Science Award, Lab Sustainability Award). The organization also maintains a community of over 2,100 EMBO Members, a Young Investigator Network of more than 600 scientists, and a Fellows community.

Differentiator

Problem solved

Functional benefit

Brands

• EMBO Press: EMBO's scientific publishing division including The EMBO Journal, EMBO reports, Molecular Systems Biology, EMBO Molecular Medicine, Life Science Alliance, and Review Commons.
• EMBO Young Investigator Network
• EMBO Global Investigator Network
• EMBO Courses & Workshops Programme

Products and services

• Postdoctoral Fellowships Long-term and short-term fellowships for postdoctoral researchers to conduct life sciences research in Europe and EMBC member states.

Quantifiable outcome

• Over 2,100 leading life scientists in membership
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature3 records

Partnerships

Eight partnerships are on record, tiered major, core and minor.

• Helmholtz AssociationmajorStrategic or Co-development Partner · 6 March 2026EMBO and the Helmholtz Association jointly organized the workshop 'Biomedical Engineering – Science Translation for Future Health' on 3-4 March 2026. The workshop explored how to support biomedical engineering as a driver for innovation and economic growth in Europe.
• ASAPbiocoreStrategic or Co-development Partner · 1 January 2019EMBO and ASAPbio co-founded Review Commons, a journal-independent peer review platform for preprints. The platform allows authors to obtain expert peer review before journal submission, with reviews posted alongside preprints.
• India (EMBC Associate Member State)coreStrategic or Co-development Partner · 4 February 2016India became the second EMBC Associate Member State (after Singapore in 2015) following a cooperation agreement signed by EMBO, EMBC, and the Government of India. Indian researchers can now participate in all EMBO programmes and activities.
• EMBL (European Molecular Biology Laboratory)coreStrategic or Co-development PartnerEMBO works closely with EMBL, providing Young Investigators and Installation Grantees access to core facilities at EMBL in Heidelberg. EMBL was established as a special project of EMBC with EMBO's involvement.
• EMBO Press Partners (Rockefeller University Press, Cold Spring Harbor Laboratory Press)majorTechnology or IntegrationEMBO Press journals are published together with Rockefeller University Press and Cold Spring Harbor Laboratory Press. The Life Science Alliance journal is jointly published with these partners.
• Review Commons Affiliate JournalsmajorTechnology or Integration17 journals collaborate with Review Commons to accelerate formal publication by reusing preprint peer reviews, including EMBO Press journals, PLOS, the Company of Biologists, eLife, Molecular Biology of the Cell, and Journal of Cell Biology.
• The Company of BiologistsminorStrategic or Co-development PartnerEMBO and The Company of Biologists jointly fund courses and workshops in Brazil, Canada, China, Japan, Mexico, and South Korea. Additional funding of 10,000 euros is available for hybrid meeting formats.
• Singapore (EMBC Associate Member State)coreStrategic or Co-development PartnerSingapore was the first EMBC Associate Member State, with a cooperation agreement signed in July 2015 enabling Singapore-based researchers to participate in EMBO programmes.

Scale indicators5 records

Recent moves13 records

Expansion highlights5 records

Direct peers

• American Society for Cell Biology (ASCB): ASCB is a US-based professional society for cell biologists that provides fellowships, awards, conferences, and publishing. Comparable to EMBO as a discipline-specific scientific society serving the molecular/cellular biology community.
• Wellcome Trust: Wellcome Trust is a UK-based charitable foundation supporting life sciences research through grants, fellowships, and policy advocacy. It is comparable to EMBO in mission (funding excellent life scientists), funding model (foundation/endowment), and program structure (fellowships, grants, publishing).
• Howard Hughes Medical Institute (HHMI): HHMI is a major US-based biomedical research organization that funds life scientists through investigator awards and research grants. It is directly comparable as a life sciences funding organization and is already a financial partner to EMBO (funding Review Commons).
• Federation of European Biochemical Societies (FEBS): FEBS is a European umbrella organization for biochemistry and molecular biology societies that funds fellowships, courses, workshops, and publications. It is directly comparable as a European life sciences funding body and collaborates with EMBO on joint programs (FEBS|EMBO Women in Science Award, FEBS|EMBO Lecture Courses).
• Cold Spring Harbor Laboratory Press: CSHL Press publishes peer-reviewed journals and books in molecular biology and genetics. It is a direct peer and active partner to EMBO Press, jointly publishing Life Science Alliance journal and other initiatives.
• American Association for the Advancement of Science (AAAS): AAAS is a US-based scientific organization that promotes science through journals (Science), fellowships, awards, and policy advocacy. Comparable to EMBO in its broad mission of promoting scientific excellence and its combination of publishing, fellowships, and policy activities.

Broad incumbents

• Springer Nature: Springer Nature is a major academic publisher and EMBO's publishing partner for distribution of EMBO Press journals. While a much larger commercial entity, it is comparable as a scientific publishing platform and infrastructure provider.
• Royal Society: The Royal Society is the UK's national academy of sciences and a global incumbent in scientific excellence recognition, funding, and policy. It is broader in scope than EMBO (all sciences vs. life sciences) but comparable in its fellowship model and influence on European research policy.
• National Institutes of Health (NIH): NIH is the largest public funder of biomedical research in the world. Comparable to EMBO at a mission level (supporting life sciences research) though much larger and broader in scope, providing grants, training, and conducting intramural research.

Emerging players

• PLOS (Public Library of Science): PLOS is an open-access scientific publisher that is an affiliate of EMBO's Review Commons platform. Comparable as an open science publisher with overlapping journal portfolio in life sciences, but operates as a distinct publishing model rather than a comprehensive scientific organization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/EMBO
• YouTubeyoutube.com/c/EMBOcomm
• Facebookfacebook.com/EMBO.excellence.in.life.sciences
• LinkedInlinkedin.com/company/european-molecular-biology-organization
• Instagraminstagram.com/emboscience

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EMBO